Dirk Seiffge
24Patents
10h-index
18Co-inventors
68Inventor score
Filing activity: Jul 19, 1985 → May 20, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5693621A | Malonic acid derivatives having antiadhesive properties | Chemistry; Metallurgy | 89 | Expired |
| US5858994A | Carbohydrate conjugates as inhibitors of cell adhesion | Chemistry; Metallurgy | 51 | Expired |
| US6136790A | Carbohydrate mimetics having antiadhesive properties | Chemistry; Metallurgy | 46 | Expired |
| US5811405A | Multiply fucosylated dicarboxylic acids possessing antiadhesive properties | Chemistry; Metallurgy | 40 | Expired |
| US5739300A | Antiadhesive piperidine-and pyrrolidinecarboxylic acids | Human Necessities | 40 | Expired |
| US5998447A | Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists | Chemistry; Metallurgy | 30 | Expired |
| US5508275A | Lipid-selective antioxidants and their preparation and use | Chemistry; Metallurgy | 27 | Expired |
| US4850489A | Dispensing packs containing pharmaceutical combinations for sequential administration | Human Necessities | 27 | Expired |
| US5318987A | Lipid-selective antioxidants and their preparation and use | Chemistry; Metallurgy | 19 | Expired |
| US4880791A | Combination product composed of xanthine derivatives and O-acetylsalicylic acid or its pharmacologically tolerated salts, and its use | Human Necessities | 16 | Expired |
| US6331552A | Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4983514A | Method for detecting the antiaggregatory effect of vasoactive substances, specifically of inhibitors of phosphodiesterase and/or cyclooxygenase | Chemistry; Metallurgy | 7 | Expired |
| US6514952B1 | Hydantoin derivatives as inhibitors of leucocyte adhesion and as VLA-4 antagonists | Chemistry; Metallurgy | 7 | Expired |
| US6034238A | Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists | Emerging Cross-Sectional Technologies | 6 | Expired |
| US4975432A | Method of using pentoxifylline for treating inflammation | Human Necessities | 5 | Expired |
| US6838439B2 | Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5556854A | Pyridopyrimidinediones, processes for their preparation and their use as drugs | Human Necessities | 5 | Expired |
| US6521654B2 | Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them | Emerging Cross-Sectional Technologies | 4 | Expired |
| US4694024A | Combination product composed of pyrimido-pyrimidines and O-acetylsalicylic acid or its pharmacologically tolerated salts, and its use | Human Necessities | 3 | Expired |
| US6423712B1 | 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6399643B1 | Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom | Human Necessities | 2 | Expired |
| US6759424B2 | Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5356922A | Imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediates | Chemistry; Metallurgy | 1 | Expired |
| US5232922A | Imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediates | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.